News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KIRSKE DAVID
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 200,000 options to buy
@ $4.55, valued at
$910k
|
|
| 01/03/2023 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 13,174 shares
@ $6, valued at
$79k
Granted 214 shares
@ $5.1085, valued at
$1.1k
Sold 12,000 shares
@ $6, valued at
$72k
Sold 800 shares
@ $6.005, valued at
$4.8k
Sold 1,047 shares
@ $6.01, valued at
$6.3k
Sold 27,021 shares
@ $6.011, valued at
$162.4k
Exercised 13,174 options to buy
@ $0.9489, valued at
$12.5k
Exercised 12,000 options to buy
@ $0.9489, valued at
$11.4k
Exercised 800 options to buy
@ $0.9489, valued at
$759.1
Exercised 1,047 options to buy
@ $0.9489, valued at
$993.5
Exercised 27,021 options to buy
@ $0.9489, valued at
$25.6k
|
|
| 10/06/2022 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 1,400 shares
@ $6.25, valued at
$8.8k
Sold 100 shares
@ $6.26, valued at
$626
Sold 609 shares
@ $6.27, valued at
$3.8k
Exercised 1,400 options to buy
@ $0.9489, valued at
$1.3k
Exercised 100 options to buy
@ $0.9489, valued at
$94.9
Exercised 609 options to buy
@ $0.9489, valued at
$577.9 |
|
| 10/03/2022 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 800 shares
@ $6, valued at
$4.8k
Sold 100 shares
@ $6.01, valued at
$601
Sold 139,841 shares
@ $6.0465, valued at
$845.5k
Sold 300 shares
@ $6.25, valued at
$1.9k
Exercised 800 options to buy
@ $0.9489, valued at
$759.1
Exercised 100 options to buy
@ $0.9489, valued at
$94.9
Exercised 139,841 options to buy
@ $0.9489, valued at
$132.7k
Exercised 300 options to buy
@ $0.9489, valued at
$284.7 |
|
| 09/20/2022 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 9,516 shares
@ $2.1165, valued at
$20.1k
Sold 22,592 shares
@ $6.02, valued at
$136k
Exercised 22,592 options to buy
@ $0.9489, valued at
$21.4k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2019 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 500,000 options to buy
@ $0.9489, valued at
$474.5k
|
|
| 09/20/2018 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 125,000 options to buy
@ $1.88, valued at
$235k
|
|
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|